The Lynch syndrome test is based on Whole Genome Sequencing Test. As such, it analyzes all Common and Rare Variants associated with Lynch syndrome instead of a limited set of genes. Lynch syndrome, often called hereditary nonpolyposis colorectal cancer (HNPCC), is an inherited disorder that increases the risk of many types of cancer, particularly cancers of the colon (large intestine) and rectum, which are collectively referred to as colorectal cancer. People with Lynch syndrome also have an increased risk of cancers of the stomach, small intestine, liver, gallbladder ducts, urinary tract, brain, and skin. Additionally, women with this disorder have a high risk of cancer of the ovaries and lining of the uterus (endometrial cancer). Women with Lynch syndrome have a higher overall risk of developing cancer than men with the condition because of these cancers of the female reproductive system. Individuals with Lynch syndrome typically develop cancer in their forties or fifties. Along with environmental factors, Genetics plays a key role in the regulation of Fibromyalgia. - 78 genes analyzed - 100% of genomic regions covered - Intragenic and intergenic regions analyzed - All variants paneled